Neil Josephson - 05 Jul 2022 Form 4 Insider Report for Zymeworks Inc.

Role
Chief Medical Officer
Signature
/s/ Daniel Dex, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
05 Jul 2022
Net transactions value
+$6,878
Form type
4
Filing time
05 Jul 2022, 21:00:38 UTC
Previous filing
11 Mar 2022
Next filing
14 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZYME Common Shares Award $6,878 +1,525 +16% $4.51 11,039 05 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to the Issuer's Amended and Restated Employee Stock Purchase Plan (ESPP) for the ESPP purchase period January 1, 2022 through June 30, 2022. In accordance with the ESPP, these shares were purchased at a price equal to 85% the closing price of the Issuer's common shares on June 30, 2022.